4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Ketamine is combined with Gamma Hydroxybutyric Acid.
Abiraterone
The serum concentration of Ketamine can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Ketamine is combined with Acepromazine.
Advertisement
Aceprometazine
The risk or severity of adverse effects can be increased when Ketamine is combined with Aceprometazine.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Ketamine.
Alfaxalone
The risk or severity of adverse effects can be increased when Ketamine is combined with Alfaxalone.
Advertisement
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Ketamine.
Alphaprodine
The risk or severity of adverse effects can be increased when Ketamine is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Ketamine.
Advertisement
Amiodarone
The metabolism of Ketamine can be decreased when combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Ketamine is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Ketamine is combined with Amitriptyline.
Amobarbital
The risk or severity of adverse effects can be increased when Ketamine is combined with Amobarbital.
Amoxapine
The risk or severity of adverse effects can be increased when Ketamine is combined with Amoxapine.
Apalutamide
The serum concentration of Ketamine can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Ketamine can be increased when it is combined with Aprepitant.
Aripiprazole
The risk or severity of adverse effects can be increased when Ketamine is combined with Aripiprazole.
Articaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Ketamine is combined with Asenapine.
Atazanavir
The metabolism of Ketamine can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Ketamine can be decreased when combined with Atomoxetine.
Azelastine
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Ketamine is combined with Baclofen.
Barbital
The risk or severity of adverse effects can be increased when Ketamine is combined with Barbital.
Benoxinate
The risk or severity of adverse effects can be increased when Ketamine is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Ketamine is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Benzocaine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Ketamine is combined with Benzyl alcohol.
Boceprevir
The metabolism of Ketamine can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Ketamine can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Ketamine can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Ketamine.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Ketamine.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Ketamine.
Brexpiprazole
The risk or severity of adverse effects can be increased when Ketamine is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ketamine.
Bromazepam
The risk or severity of adverse effects can be increased when Ketamine is combined with Bromazepam.
Bromperidol
The risk or severity of adverse effects can be increased when Ketamine is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Ketamine is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Ketamine is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Bupivacaine.
Buprenorphine
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Ketamine.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Ketamine.
Butalbital
The risk or severity of adverse effects can be increased when Ketamine is combined with Butalbital.
Butamben
The risk or severity of adverse effects can be increased when Ketamine is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Ketamine is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ketamine.
Capecitabine
The metabolism of Ketamine can be decreased when combined with Capecitabine.
Carbamazepine
The metabolism of Ketamine can be increased when combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Carbinoxamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Ketamine is combined with Carisoprodol.
Celecoxib
The metabolism of Ketamine can be decreased when combined with Celecoxib.
Ceritinib
The serum concentration of Ketamine can be increased when it is combined with Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Ketamine is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Ketamine is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Ketamine.
Chlormethiazole
The risk or severity of adverse effects can be increased when Ketamine is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Ketamine is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Chloroprocaine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Ketamine is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Ketamine is combined with Chlorphenamine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Ketamine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Ketamine is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Ketamine is combined with Chlorzoxazone.
Cholecalciferol
The metabolism of Ketamine can be decreased when combined with Cholecalciferol.
Citalopram
The metabolism of Ketamine can be decreased when combined with Citalopram.
Clarithromycin
The metabolism of Ketamine can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Ketamine can be decreased when combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Ketamine is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Ketamine is combined with Clidinium.
Clobazam
The risk or severity of adverse effects can be increased when Ketamine is combined with Clobazam.
Clofezone
The metabolism of Ketamine can be decreased when combined with Rabeprazole.
Clomipramine
The risk or severity of adverse effects can be increased when Ketamine is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Ketamine is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Ketamine is combined with Clonidine.
Clopidogrel
The metabolism of Ketamine can be decreased when combined with Clopidogrel.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Ketamine.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Ketamine.
Clotrimazole
The metabolism of Ketamine can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Ketamine.
Cobicistat
The metabolism of Ketamine can be decreased when combined with Cobicistat.
Cocaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Ketamine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Ketamine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Ketamine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Ketamine.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Ketamine.
Crisaborole
The metabolism of Ketamine can be decreased when combined with Crisaborole.
Crizotinib
The metabolism of Ketamine can be decreased when combined with Crizotinib.
Cyclizine
The risk or severity of adverse effects can be increased when Ketamine is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Ketamine.
Cyclosporine
The metabolism of Ketamine can be decreased when combined with Cyclosporine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Ketamine is combined with Cyproheptadine.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Ketamine.
Dabrafenib
The serum concentration of Ketamine can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of adverse effects can be increased when Ketamine is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Ketamine is combined with Dapiprazole.
Darunavir
The metabolism of Ketamine can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Ketamine can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Ketamine can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Ketamine can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Ketamine can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Ketamine.
Desipramine
The metabolism of Ketamine can be decreased when combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Ketamine is combined with Desloratadine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Ketamine is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Ketamine is combined with Dexbrompheniramine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Ketamine is combined with Dexmedetomidine.
Dextromoramide
The risk or severity of adverse effects can be increased when Ketamine is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Ketamine is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Ketamine.
Dibucaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Cinchocaine.
Difenoxin
The risk or severity of adverse effects can be increased when Ketamine is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Ketamine is combined with Dihydrocodeine.
Dihydroergotamine
The metabolism of Ketamine can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Ketamine can be decreased when combined with Diltiazem.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Ketamine is combined with Dimenhydrinate.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Ketamine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Ketamine.
Dothiepin
The metabolism of Ketamine can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Ketamine is combined with Doxepin.
Doxorubicin
The metabolism of Ketamine can be decreased when combined with Doxorubicin.
Doxorubicin Hydrochloride
The metabolism of Ketamine can be decreased when combined with Doxorubicin.
Doxycycline
The metabolism of Ketamine can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Ketamine can be decreased when combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Ketamine.
Dronedarone
The metabolism of Ketamine can be decreased when combined with Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ketamine.
Duloxetine
The risk or severity of adverse effects can be increased when Ketamine is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Ketamine is combined with Dyclonine.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Ketamine.
Efavirenz
The metabolism of Ketamine can be decreased when combined with Efavirenz.
Enflurane
The risk or severity of adverse effects can be increased when Ketamine is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Ketamine is combined with Entacapone.
Enzalutamide
The serum concentration of Ketamine can be decreased when it is combined with Enzalutamide.
Erythromycin
The metabolism of Ketamine can be decreased when combined with Erythromycin.
Escitalopram
The risk or severity of adverse effects can be increased when Ketamine is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Ketamine.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ketamine.
Ethanol
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Ketamine is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Ketamine is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Ketamine is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Ketamine is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Ketamine is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ketamine is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Ketamine is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Ketamine is combined with Etomidate.
Etravirine
The metabolism of Ketamine can be decreased when combined with Etravirine.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Ketamine.
Ezogabine
The risk or severity of adverse effects can be increased when Ketamine is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Ketamine is combined with Felbamate.
Felodipine
The metabolism of Ketamine can be decreased when combined with Felodipine.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Ketamine.
Fexofenadine
The risk or severity of adverse effects can be increased when Ketamine is combined with Fexofenadine.
Flibanserin
The risk or severity of adverse effects can be increased when Ketamine is combined with Flibanserin.
Floxuridine
The metabolism of Ketamine can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Ketamine can be decreased when combined with Fluconazole.
Flunarizine
The risk or severity of adverse effects can be increased when Ketamine is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Ketamine is combined with Flunitrazepam.
Fluorouracil
The metabolism of Ketamine can be decreased when combined with Fluorouracil.
Fluoxetine
The risk or severity of adverse effects can be increased when Ketamine is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Ketamine.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ketamine.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Ketamine.
Fluspirilene
The risk or severity of adverse effects can be increased when Ketamine is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Ketamine is combined with Fluticasone propionate.
Fluvastatin
The metabolism of Ketamine can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Ketamine can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Ketamine can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Ketamine can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Ketamine can be increased when combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Ketamine is combined with Fospropofol.
Fusidate
The serum concentration of Ketamine can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Ketamine can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Ketamine.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Ketamine is combined with Gabapentin Enacarbil.
Gemfibrozil
The metabolism of Ketamine can be decreased when combined with Gemfibrozil.
Glutethimide
The risk or severity of adverse effects can be increased when Ketamine is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Ketamine is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Ketamine is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Ketamine.
Halothane
The risk or severity of adverse effects can be increased when Ketamine is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Ketamine is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Ketamine is combined with Hexobarbital.
Hydrocodone
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ketamine.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ketamine.
Hypoxis hemerocallidea root extract
The serum concentration of Ketamine can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Ketamine can be decreased when combined with Idelalisib.
Iloperidone
The risk or severity of adverse effects can be increased when Ketamine is combined with Iloperidone.
Imatinib
The metabolism of Ketamine can be decreased when combined with Imatinib.
Imipramine
The risk or severity of adverse effects can be increased when Ketamine is combined with Imipramine.
Indinavir
The metabolism of Ketamine can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Ketamine can be decreased when combined with Indinavir.
Irbesartan
The metabolism of Ketamine can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Ketamine can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Ketamine can be decreased when combined with Isavuconazonium.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Ketamine.
Isradipine
The metabolism of Ketamine can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Ketamine can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Ketamine can be increased when it is combined with Ivacaftor.
Ketazolam
The risk or severity of adverse effects can be increased when Ketamine is combined with Ketazolam.
Ketoconazole
The metabolism of Ketamine can be decreased when combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Ketamine is combined with Lamotrigine.
Lapatinib
The metabolism of Ketamine can be decreased when combined with Lapatinib.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Ketamine.
Leflunomide
The metabolism of Ketamine can be decreased when combined with Leflunomide.
Levetiracetam
The risk or severity of adverse effects can be increased when Ketamine is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Ketamine is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Ketamine is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Ketamine is combined with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Ketamine is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Ketamine is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Ketamine.
Lidocaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Lidocaine.
Lithium
The risk or severity of adverse effects can be increased when Ketamine is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Ketamine is combined with Lithium.
Lopinavir
The metabolism of Ketamine can be decreased when combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Ketamine is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Ketamine.
Lormetazepam
The risk or severity of adverse effects can be increased when Ketamine is combined with Lormetazepam.
Losartan
The metabolism of Ketamine can be decreased when combined with Losartan.
Lovastatin
The metabolism of Ketamine can be decreased when combined with Lovastatin.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Ketamine.
Luliconazole
The serum concentration of Ketamine can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Ketamine can be increased when it is combined with Lumacaftor.
Lurasidone
The risk or severity of adverse effects can be increased when Ketamine is combined with Lurasidone.
Magnesium Sulfate
The therapeutic efficacy of Ketamine can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Ketamine can be increased when used in combination with Magnesium sulfate.
Manidipine
The metabolism of Ketamine can be decreased when combined with Manidipine.
Maprotiline
The risk or severity of adverse effects can be increased when Ketamine is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Ketamine is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Ketamine is combined with Melatonin.
Memantine
The risk or severity of adverse effects can be increased when Ketamine is combined with Memantine.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Ketamine.
Mephobarbital
The risk or severity of adverse effects can be increased when Ketamine is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Ketamine.
Mesoridazine
The risk or severity of adverse effects can be increased when Ketamine is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Ketamine is combined with Metaxalone.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Ketamine.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Ketamine is combined with Methadyl Acetate.
Methapyrilene
The risk or severity of adverse effects can be increased when Ketamine is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Ketamine is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Ketamine is combined with Methocarbamol.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Ketamine.
Methotrimeprazine
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Ketamine is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Ketamine is combined with Methsuximide.
Metylperon
The risk or severity of adverse effects can be increased when Ketamine is combined with Melperone.
Metyrosine
Ketamine may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Ketamine.
Midostaurin
The metabolism of Ketamine can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Ketamine can be increased when it is combined with Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Ketamine is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ketamine.
Mirtazapine
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Mitotane
The serum concentration of Ketamine can be decreased when it is combined with Mitotane.
Molindone
The risk or severity of adverse effects can be increased when Ketamine is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Ketamine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Ketamine.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ketamine.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Ketamine.
Nefazodone
The metabolism of Ketamine can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Ketamine can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Ketamine can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Ketamine can be increased when combined with Nevirapine.
Nicardipine
The metabolism of Ketamine can be decreased when combined with Nicardipine.
Nilotinib
The metabolism of Ketamine can be decreased when combined with Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Ketamine is combined with Nitrazepam.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Ketamine is combined with Nitrous oxide.
Norflurane
The risk or severity of adverse effects can be increased when Ketamine is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Ketamine is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Ketamine is combined with Nortriptyline.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Ketamine.
Olaparib
The metabolism of Ketamine can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Ketamine is combined with Olopatadine.
Omeprazole
The metabolism of Ketamine can be decreased when combined with Omeprazole.
Ondansetron
The risk or severity of adverse effects can be increased when Ketamine is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Ketamine is combined with Opium.
Orphenadrine
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Ketamine can be increased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Ketamine.
Oxprenolol
The risk or severity of adverse effects can be increased when Ketamine is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Ketamine.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Ketamine.
Palbociclib
The serum concentration of Ketamine can be increased when it is combined with Palbociclib.
Paliperidone
The risk or severity of adverse effects can be increased when Ketamine is combined with Paliperidone.
Paraldehyde
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Ketamine.
Paroxetine
The metabolism of Ketamine can be decreased when combined with Paroxetine.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Ketamine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Ketamine.
Pentobarbital
The metabolism of Ketamine can be increased when combined with Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Ketamine.
Perazine
The risk or severity of adverse effects can be increased when Ketamine is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Ketamine.
Phenobarbital
The metabolism of Ketamine can be increased when combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Ketamine is combined with Phenoxyethanol.
Phenytoin
The metabolism of Ketamine can be increased when combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Ketamine.
Pioglitazone
The metabolism of Ketamine can be decreased when combined with Pioglitazone.
Pipamperone
The risk or severity of adverse effects can be increased when Ketamine is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Ketamine is combined with Pipotiazine.
Pirinitramide
The risk or severity of adverse effects can be increased when Ketamine is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Ketamine is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Ketamine is combined with Pomalidomide.
Posaconazole
The metabolism of Ketamine can be decreased when combined with Posaconazole.
Pramipexole
Ketamine may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Ketamine is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Ketamine is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Ketamine can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Prilocaine.
Primidone
The metabolism of Ketamine can be increased when combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Procaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Ketamine.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Ketamine.
Promethazine
The risk or severity of adverse effects can be increased when Ketamine is combined with Promethazine.
Proparacaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Ketamine.
Propoxyphene
The risk or severity of adverse effects can be increased when Ketamine is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Ketamine is combined with Protriptyline.
Pyrimethamine
The metabolism of Ketamine can be decreased when combined with Pyrimethamine.
Quazepam
The serum concentration of Ketamine can be increased when it is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Ketamine is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Ketamine is combined with Quetiapine.
Quinine
The metabolism of Ketamine can be decreased when combined with Quinine.
Rabeprazole
The metabolism of Ketamine can be decreased when combined with Rabeprazole.
Ramelteon
The risk or severity of adverse effects can be increased when Ketamine is combined with Ramelteon.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Ketamine.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ketamine.
Remoxipride
The risk or severity of adverse effects can be increased when Ketamine is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Ketamine.
Rifabutin
The metabolism of Ketamine can be increased when combined with Rifabutin.
Rifampin
The metabolism of Ketamine can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Ketamine can be increased when combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Ketamine.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Ketamine.
Ropinirole
Ketamine may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Ropivacaine.
Rosiglitazone
The metabolism of Ketamine can be decreased when combined with Rosiglitazone.
Rotigotine
Ketamine may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Ketamine can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Ketamine.
Saquinavir
The metabolism of Ketamine can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Ketamine can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Ketamine can be decreased when used in combination with Sarilumab.
Scopolamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Scopolamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Ketamine is combined with Scopolamine.
Secobarbital
The metabolism of Ketamine can be increased when combined with Secobarbital.
Sertindole
The risk or severity of adverse effects can be increased when Ketamine is combined with Sertindole.
Sertraline
The metabolism of Ketamine can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Ketamine is combined with Sevoflurane.
Sildenafil
The metabolism of Ketamine can be decreased when combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Ketamine.
Siltuximab
The serum concentration of Ketamine can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Ketamine can be increased when it is combined with Simeprevir.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Ketamine.
Sorafenib
The metabolism of Ketamine can be decreased when combined with Sorafenib.
ST. JOHN'S WORT EXTRACT
The serum concentration of Ketamine can be decreased when it is combined with St. John's Wort.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Ketamine.
Sulfadiazine
The metabolism of Ketamine can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Ketamine can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Ketamine can be decreased when combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Ketamine is combined with Sulpiride.
Suvorexant
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tamoxifen
The metabolism of Ketamine can be decreased when combined with Tamoxifen.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ketamine.
Tasimelteon
The risk or severity of adverse effects can be increased when Ketamine is combined with Tasimelteon.
Telaprevir
The metabolism of Ketamine can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Ketamine can be decreased when combined with Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Ketamine.
Teriflunomide
The metabolism of Ketamine can be decreased when combined with Teriflunomide.
Tetrabenazine
The risk or severity of adverse effects can be increased when Ketamine is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Ketamine is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Ketamine is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Ketamine.
Thalidomide
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Ketamine is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Ketamine is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Ketamine is combined with Thiopental.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Ketamine.
Thiotepa
The metabolism of Ketamine can be decreased when combined with Thiotepa.
Thiothixene
The risk or severity of adverse effects can be increased when Ketamine is combined with Thiothixene.
Tiagabine
The risk or severity of adverse effects can be increased when Ketamine is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Ketamine is combined with Tiapride.
Ticagrelor
The metabolism of Ketamine can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Ketamine can be decreased when combined with Ticlopidine.
Tizanidine
The risk or severity of adverse effects can be increased when Ketamine is combined with Tizanidine.
Tocilizumab
The serum concentration of Ketamine can be decreased when it is combined with Tocilizumab.
Tolbutamide
The metabolism of Ketamine can be decreased when combined with Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Ketamine is combined with Tolcapone.
Topiramate
The risk or severity of adverse effects can be increased when Ketamine is combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Ketamine.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Ketamine.
Tranylcypromine
The risk or severity of adverse effects can be increased when Ketamine is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Ketamine is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Ketamine.
Triazulenone
The risk or severity of adverse effects can be increased when Ketamine is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ketamine.
Triflupromazine
The risk or severity of adverse effects can be increased when Ketamine is combined with Triflupromazine.
Trimethoprim
The metabolism of Ketamine can be decreased when combined with Trimethoprim.
Trimipramine
The risk or severity of adverse effects can be increased when Ketamine is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Ketamine is combined with Triprolidine.
Urethane
The risk or severity of adverse effects can be increased when Ketamine is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Ketamine is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Ketamine is combined with Valproic Acid.
Valsartan
The metabolism of Ketamine can be decreased when combined with Valsartan.
Vemurafenib
The serum concentration of Ketamine can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Ketamine can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Ketamine can be decreased when combined with Verapamil.
Vigabatrin
The risk or severity of adverse effects can be increased when Ketamine is combined with Vigabatrin.
Vincristine
The excretion of Vincristine can be decreased when combined with Ketamine.
Voriconazole
The metabolism of Ketamine can be decreased when combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Ketamine is combined with Vortioxetine.
Zafirlukast
The metabolism of Ketamine can be decreased when combined with Zafirlukast.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Ketamine.
Ziconotide
The risk or severity of adverse effects can be increased when Ketamine is combined with Ziconotide.
Ziprasidone
The metabolism of Ketamine can be decreased when combined with Ziprasidone.
Zolpidem
Ketamine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Ketamine is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Ketamine.
Zotepine
The risk or severity of adverse effects can be increased when Ketamine is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Ketamine is combined with Zuclopenthixol.
